Freyr · Account Report
BioNex Therapeutics
bionextherapeutics.com
Generated
Jul 22, 2026
Industry
Biotechnology
Geography
United States (Princeton, NJ) — offices in London, Singapore
Size
Mid-size
Owner
Diego Alvarez
Competitor
—
Open value
$250K
Account summary
Mid-size clinical-stage biopharma, ~450 employees, Series D, 3 Phase 2 compounds + 1 NDA-ready. Focus on biologics for oncology and autoimmune. Working across FDA and EMA.
Buying committee (1)
- Dr. Priya MehtaVP Regulatory Affairs
Deals (1)
- Regulatory Submission ServicesEngaged · $250K
Recommended Freyr services
- Regulatory Submission Services
- Regulatory Intelligence
Recent activity
- In Progress — Had intro call. She is interested in CTD dossier support. Sending proposal next week.Jul 16, 2026 • 4:58 PM